Stock listing
gettex:38P Pihlajalinna PLC Aktie
German listing (gettex) of Pihlajalinna PLC · home listing Helsinki:PIHLIS
Follow Pihlajalinna PLC into a list and get an email when it puts out news.
Home listing price · OMXHEX:PIHLIS
€8.28 EUR -0.14 (-1.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXHEX:PIHLIS
- Day range
- €8.27 – €8.38 EURNov 20, 2026
- Volume
- 34,160 sharesNov 20, 2026
- Market cap
- €186.2M EURAt the close on Nov 20, 2026 · price × 22.49M shares outstanding
- 52-week range
- €8.27 – €14.90 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €294,828 EURMedian day 20,278 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Helsinki:PIHLIS · Home | €8.28 EUR | -0.14 (-1.7%) | 34,160 | €8.36 | €8.38 | €8.27 | €8.42 | Close on Nov 20, 2026 |
| LSE:0R8H | €8.30 EUR | -0.08 (-1.0%) | 2,356 | €8.30 | €8.35 | €8.27 | €8.38 | Close on Nov 20, 2026 |
| Frankfurt:38P | €8.23 EUR | -0.17 (-2.0%) | — | €8.23 | €8.23 | €8.23 | €8.40 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXHEX:PIHLIS · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €8.28 | -0.14 | -1.7% | €8.36 | €8.38 | €8.27 | 34,160 | |
| €8.42 | -0.02 | -0.2% | €8.48 | €8.50 | €8.40 | 15,693 | |
| €8.44 | -0.10 | -1.2% | €8.63 | €8.63 | €8.42 | 23,485 | |
| €8.54 | 0.00 | 0.0% | €8.76 | €8.76 | €8.52 | 16,758 | |
| €8.54 | +0.06 | +0.7% | €8.50 | €8.58 | €8.40 | 23,114 | |
| €8.48 | +0.01 | +0.1% | €8.49 | €8.54 | €8.44 | 19,352 | |
| €8.47 | +0.12 | +1.4% | €8.39 | €8.50 | €8.38 | 20,299 | |
| €8.35 | -0.13 | -1.5% | €8.48 | €8.54 | €8.35 | 45,002 | |
| €8.48 | -0.19 | -2.2% | €8.69 | €8.73 | €8.48 | 27,443 | |
| €8.67 | +0.17 | +2.0% | €8.55 | €8.73 | €8.53 | 34,361 | |
| €8.50 | -0.01 | -0.1% | €8.55 | €8.63 | €8.50 | 20,619 | |
| €8.51 | +0.08 | +0.9% | €8.47 | €8.62 | €8.45 | 31,712 | |
| €8.43 | -0.16 | -1.9% | €8.59 | €8.59 | €8.42 | 59,197 | |
| €8.59 | +0.03 | +0.4% | €8.56 | €8.67 | €8.56 | 34,695 | |
| €8.56 | -0.09 | -1.0% | €8.70 | €8.70 | €8.54 | 36,242 | |
| €8.65 | -0.29 | -3.2% | €8.94 | €8.94 | €8.65 | 38,705 | |
| €8.94 | +0.30 | +3.5% | €8.64 | €9.05 | €8.64 | 37,291 | |
| €8.64 | -0.06 | -0.7% | €8.76 | €8.89 | €8.61 | 59,195 | |
| €8.70 | -0.19 | -2.1% | €8.90 | €9.05 | €8.70 | 117,901 | |
| €8.89 | -1.69 | -16.0% | €9.70 | €9.89 | €8.88 | 393,191 | |
| €10.58 | +0.12 | +1.1% | €10.44 | €10.68 | €10.20 | 47,632 | |
| €10.46 | -0.12 | -1.1% | €10.64 | €10.74 | €10.46 | 27,430 | |
| €10.58 | -0.04 | -0.4% | €10.68 | €10.70 | €10.58 | 11,097 | |
| €10.62 | -0.20 | -1.8% | €10.82 | €10.84 | €10.62 | 25,714 | |
| €10.82 | +0.32 | +3.0% | €10.62 | €11.10 | €10.60 | 44,889 | |
| €10.50 | -0.04 | -0.4% | €10.58 | €10.66 | €10.50 | 14,994 | |
| €10.54 | -0.08 | -0.8% | €10.62 | €10.64 | €10.46 | 9,741 | |
| €10.62 | +0.16 | +1.5% | €10.58 | €10.70 | €10.46 | 23,252 | |
| €10.46 | -0.10 | -0.9% | €10.54 | €10.58 | €10.46 | 13,702 | |
| €10.56 | -0.02 | -0.2% | €10.62 | €10.70 | €10.56 | 17,572 | |
| €10.58 | +0.12 | +1.1% | €10.46 | €10.68 | €10.46 | 20,148 | |
| €10.46 | +0.02 | +0.2% | €10.48 | €10.58 | €10.46 | 10,159 | |
| €10.44 | -0.22 | -2.1% | €10.68 | €10.68 | €10.44 | 24,290 | |
| €10.66 | -0.22 | -2.0% | €10.88 | €10.90 | €10.66 | 15,555 | |
| €10.88 | +0.22 | +2.1% | €10.78 | €10.94 | €10.74 | 17,945 | |
| €10.66 | -0.24 | -2.2% | €10.80 | €10.88 | €10.66 | 15,399 | |
| €10.90 | -0.10 | -0.9% | €11.06 | €11.24 | €10.80 | 34,780 | |
| €11.00 | +0.18 | +1.7% | €10.90 | €11.18 | €10.88 | 25,496 | |
| €10.82 | +0.02 | +0.2% | €10.84 | €10.96 | €10.78 | 28,338 | |
| €10.80 | -0.16 | -1.5% | €11.02 | €11.04 | €10.80 | 20,277 | |
| €10.96 | -0.18 | -1.6% | €11.16 | €11.16 | €10.96 | 25,097 | |
| €11.14 | +0.14 | +1.3% | €11.10 | €11.20 | €11.06 | 16,242 | |
| €11.00 | -0.14 | -1.3% | €11.18 | €11.28 | €11.00 | 21,207 | |
| €11.14 | -0.26 | -2.3% | €11.34 | €11.38 | €11.12 | 46,101 | |
| €11.40 | +0.76 | +7.1% | €10.86 | €11.40 | €10.86 | 74,906 | |
| €10.64 | -0.02 | -0.2% | €10.62 | €10.70 | €10.56 | 6,432 | |
| €10.66 | -0.10 | -0.9% | €10.74 | €10.80 | €10.58 | 14,607 | |
| €10.76 | +0.22 | +2.1% | €10.62 | €10.80 | €10.48 | 12,836 | |
| €10.54 | +0.02 | +0.2% | €10.56 | €10.64 | €10.54 | 4,241 | |
| €10.52 | -0.12 | -1.1% | €10.64 | €10.64 | €10.46 | 17,617 | |
| €10.64 | +0.02 | +0.2% | €10.62 | €10.76 | €10.50 | 9,740 | |
| €10.62 | -0.32 | -2.9% | €10.94 | €10.94 | €10.56 | 20,278 | |
| €10.94 | +0.02 | +0.2% | €10.94 | €10.98 | €10.80 | 16,658 | |
| €10.92 | +0.12 | +1.1% | €10.86 | €10.92 | €10.78 | 11,060 | |
| €10.80 | +0.10 | +0.9% | €10.66 | €10.80 | €10.64 | 7,779 | |
| €10.70 | -0.16 | -1.5% | €10.86 | €10.86 | €10.56 | 21,059 | |
| €10.86 | -0.08 | -0.7% | €10.90 | €11.04 | €10.78 | 20,225 | |
| €10.94 | +0.18 | +1.7% | €10.70 | €10.94 | €10.70 | 15,613 | |
| €10.76 | -0.04 | -0.4% | €10.84 | €10.84 | €10.68 | 9,703 | |
| €10.80 | -0.12 | -1.1% | €10.90 | €10.90 | €10.70 | 13,695 | |
| €10.92 | +0.16 | +1.5% | €10.76 | €10.94 | €10.70 | 8,678 | |
| €10.76 | +0.28 | +2.7% | €10.50 | €10.76 | €10.50 | 12,562 | |
| €10.48 | +0.06 | +0.6% | €10.42 | €10.52 | €10.42 | 3,809 | |
| €10.42 | -0.10 | -1.0% | €10.52 | €10.60 | €10.40 | 13,456 |
- Ticker
- gettex:38P
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Sep 25, 2026
Inside information: Pihlajalinna negotiating an acquisition to expand its operations into Central Uusimaa
Latest news
Inside information: Pihlajalinna negotiating an acquisition to expand its operations into Central Uusimaa
Sep 25, 2026
Closed €11.00 (+1.7%) on Sep 25, 2026
Inside information, profit warning: Pihlajalinna lowers its guidance for 2026
Jul 22, 2026
Closed €9.66 (-1.9%) on Jul 23, 2026
Pihlajalinna Interim Report 1 January-31 March 2026: Revenue declined as expected due to expiry of outsourcing agreements, margin remained at the previous year's level
Apr 28, 2026
Closed €10.70 (-1.8%) on Apr 28, 2026
Pihlajalinna Plc: Notice to Annual General Meeting
Mar 6, 2026
Closed €13.10 (+0.4%) on Mar 6, 2026
Pihlajalinna Oyj to launch long-term share-based incentive plan performance period 2026–2028
Feb 13, 2026
Closed €13.10 (-3.3%) on Feb 13, 2026
Pihlajalinna Financial Statements Release 1 January–31 December 2025: Strong profitability development continued in 2025
Feb 13, 2026
Closed €13.10 (-3.3%) on Feb 13, 2026
Change in Pihlajalinna’s Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer
Feb 13, 2026
Closed €13.10 (-3.3%) on Feb 13, 2026
Pihlajalinna Oyj to redeem its hybrid bond
Feb 12, 2026
Closed €13.55 (-4.9%) on Feb 12, 2026
Proposals of Pihlajalinna Plc's Shareholders' Nomination Board to the 2026 Annual General Meeting
Jan 19, 2026
Closed €14.25 (-2.1%) on Jan 19, 2026
Pihlajalinna PLC on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 11 in the last 12 months · 11 in all · newest Sep 25, 2026 · oldest 2026
- Decks
- 21 decks · latest May 9, 2025
Where Pihlajalinna PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Helsinki:PIHLIS · Home listing | Helsinki | Finland | EUR |
| LS Exchange:A14UF2 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14UF2 | Lang & Schwarz | Germany | EUR |
| LSE:0R8H | LSE | United Kingdom | EUR |
| gettex:38P · This page | gettex | Germany | EUR |
| Aquis:PIHLIH | Aquis | United Kingdom | EUR |
| Aquis:PIHLIH | Aquis | United Kingdom | EUR |
| Dusseldorf:38P | Dusseldorf | Germany | EUR |
| Frankfurt:38P | Frankfurt | Germany | EUR |
| Munich:38P | Munich | Germany | EUR |
| Stuttgart:38P | Stuttgart | Germany | EUR |
| Tradegate:38P | Tradegate | Germany | EUR |
Valuation
P/E 10.0× against a median of 10.6×: 5th lowest of 9 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- €351.0M EUR
- P/E
- 10.0×
- EV/sales
- 0.6×
- EV/EBITDA
- 4.3×
- Price/book
- 1.1×
- Gross margin
- 9.3%
- Operating margin
- 6.1%
- Net margin
- 3.4%
- Debt to equity
- 1.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Pihlajalinna PLC · OMXHEX:PIHLIS | US$204.4M | US$385.2M | 10.0× | 0.6× | 4.3× | 1.1× | 3.4% | 1.1× | n/a |
| Community Health Systems, Inc. · NYSE:CYH | US$228.5M | US$9.66B | 6.3× | 0.8× | 5.7× | n/a | 0.3% | n/a | 1.38 |
| Spok Holdings, Inc. · NASDAQ:SPOK | US$225.2M | US$195.1M | 12.0× | 1.4× | 9.2× | 1.6× | 13.9% | 0.0× | 0.10 |
| Goodwill E-Health Info Co., Ltd. Class A · SSE:688246 | US$223.0M | US$220.7M | n/a | 5.3× | n/a | 1.3× | −71.8% | 0.0× | n/a |
| PT Sarana Meditama Metropolitan Tbk · IDX:SAME | US$211.7M | US$273.6M | 204× | 2.5× | 14.9× | 1.0× | 0.9% | 0.3× | n/a |
| Atrys Health SA · BME:ATRY | US$204.1M | US$320.4M | n/a | 2.1× | n/a | 1.3× | −71.1% | 0.8× | n/a |
| Medical Facilities Corporation · TSX:DR | US$197.7M | US$180.7M | 4.9× | 0.7× | 2.9× | 2.0× | 14.8% | 0.5× | 0.22 |
| Infinitt Healthcare Co., Ltd · KRX:071200 | US$193.4M | US$33.96M | 4.0× | 0.4× | 1.7× | 1.1× | 59.1% | 0.0× | n/a |
| Krsnaa Diagnostics Limited · NSE:KRSNAA | US$190.8M | US$234.5M | 18.0× | 2.5× | 9.4× | 1.7× | 11.1% | 0.6× | n/a |
| Limes Schlosskliniken AG · XETR:LIK | US$189.7M | US$190.2M | 30.3× | 3.5× | 13.6× | 7.1× | 11.4% | 0.4× | n/a |
| Distinct Healthcare Holdings Limited · HKEX:2677 | US$188.0M | US$83.16M | 9.3× | 0.5× | 3.4× | 1.4× | 12.7% | 0.0× | n/a |
| Median of the others | US$200.9M | US$207.9M | 10.6× | 1.8× | 7.5× | 1.4× | 11.3% | 0.3× | 0.22 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 10.43 EUR · Analysts' mean
- EPS, year to Dec 2026
- 1.05 · 4 analysts
- Revenue, year to Dec 2026
- 540.1M · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Tuomas Hyyryläinen | President and CEO |
| Tarja Rantala | Chief Financial Officer |
| Jaakko Liljeroos | Chief Legal Officer |
| Heikki Färkkilä | Executive Vice President, Strategy and Group Operations |
| Mika Videman | Executive Vice President, People and culture |
| Seppo Kariniemi | Executive Vice President, Healthcare services |
| Tuula Lehto | Executive Vice President, Communications, Marketing and Sustainability |
| Heikki Tarkkila | Chief Commercial Officer |
| Lauri Muhonen | Chief Information Officer |
| Sari Riihijärvi | Chief Medical Officer |
Board
| Director | Role |
|---|---|
| Tuomas Hyyryläinen | President and CEO |
Events
- Next results
- Feb 18, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · Before open | −1.0% |
| Q2 2026 | Jul 23, 2026 · Before open | −1.9% |
| Q1 2026 | Apr 28, 2026 · Before open | −1.8% |
| Q4 2025 | Feb 12, 2026 · Before open | −4.9% |
| Q3 2025 | Oct 31, 2025 · Before open | −5.1% |
| Q2 2025 | Jul 24, 2025 · Before open | +4.0% |
| Q1 2025 | Apr 30, 2025 · Before open | +5.7% |
| Q4 2024 | Feb 12, 2025 · Before open | +7.9% |
| Q3 2024 | Nov 7, 2024 · Before open | −1.8% |
| Q2 2024 | Aug 9, 2024 · Before open | −1.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 3, 2024 · Before open | +7.8% |
| Q4 2023 | Feb 14, 2024 · Before open | −0.4% |
| Q3 2023 | Nov 3, 2023 · Before open | +0.1% |
| Q2 2023 | Aug 11, 2023 · Before open | −4.1% |
| Q1 2023 | Apr 28, 2023 · Before open | +6.8% |
| Q4 2022 | Feb 17, 2023 · Before open | −3.6% |
| Q3 2022 | Nov 4, 2022 · Before open | −2.4% |
| Q2 2022 | Aug 12, 2022 · Before open | +0.9% |
| Q1 2022 | May 5, 2022 · Before open | +4.2% |
| Q4 2021 | Feb 18, 2022 · Before open | −6.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (May 2025) | Investor day | 60 slides | May 9, 2025 |
| Q3 2021 Earnings Presentation | Earnings | 25 slides | Nov 4, 2021 |
| H1 2021 Earnings Presentation | Earnings | 21 slides | Aug 13, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 23 slides | May 7, 2021 |
| Q3 2020 Earnings Presentation | Earnings | 22 slides | Nov 4, 2020 |
| H1 2020 Earnings Presentation | Earnings | 27 slides | Aug 14, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 19 slides | May 8, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 14 slides | Nov 5, 2019 |
| H1 2019 Earnings Presentation | Earnings | 17 slides | Aug 15, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 20 slides | May 3, 2019 |
All 21 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2018 Earnings Presentation | Earnings | 7 slides | Nov 1, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 7 slides | Aug 16, 2018 |
| Q1 2018 Earnings Presentation | Earnings | 8 slides | May 4, 2018 |
| Investor Day (November 2017) | Investor day | 73 slides | Nov 22, 2017 |
| Q3 2017 Earnings Presentation | Earnings | 7 slides | Nov 9, 2017 |
| H1 2017 Earnings Presentation | Earnings | 7 slides | Aug 17, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 7 slides | May 11, 2017 |
| Q4 2016 Earnings Presentation | Earnings | 15 slides | Feb 17, 2017 |
| Q3 2016 Earnings Presentation | Earnings | 15 slides | Nov 11, 2016 |
| H1 2016 Earnings Presentation | Earnings | 16 slides | Aug 26, 2016 |
| Q1 2016 Earnings Presentation | Earnings | 24 slides | May 10, 2016 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 652.3M | 704.4M | 720.0M | 690.5M | 577.8M | 508.7M | 518.6M | 487.8M | 424.0M | 399.1M |
| Cost of revenue | 529.4M | 200.4M | 578.0M | 267.2M | 209.5M | 198.0M | 200.2M | 189.2M | 175.5M | 168.0M |
| Gross profit | 122.9M | 504.0M | 142.0M | 423.3M | 368.3M | 310.7M | 318.4M | 298.6M | 248.4M | 231.1M |
| Research and development | 1.09M | 930.0K | 961.0K | 924.0K | 1.29M | 1.83M | 314.0K | 263.0K | ||
| Selling, general and administrative | 289.6M | 321.2M | 23.0K | 362.2M | 7.83M | 6.07M | 8.05M | 7.62M | 5.62M | 4.83M |
| Operating income | 59.2M | 48.5M | 20.6M | 8.11M | 27.9M | 18.2M | 10.2M | 12.8M | 19.1M | 15.1M |
| Depreciation and amortization | 50.0M | 53.0M | 51.9M | 45.5M | 34.7M | 34.0M | 37.7M | 31.6M | 14.2M | 12.3M |
| EBITDA | 109.2M | 101.5M | 72.5M | 53.6M | 62.6M | 52.2M | 47.8M | 44.4M | 33.3M | 27.4M |
| Interest expense | 8.00M | 10.9M | 11.5M | 8.07M | 3.96M | 4.64M | 4.05M | 3.89M | 1.86M | 1.53M |
| Income before tax | 45.8M | 38.6M | 8.19M | 1.55M | 24.2M | 13.8M | 6.26M | 9.96M | 17.4M | 13.7M |
| Income tax | 7.20M | 8.50M | 3.59M | -6.11M | 5.13M | 4.84M | 1.78M | 2.81M | 3.38M | 2.95M |
| Net income | 37.6M | 27.4M | 5.73M | 9.52M | 20.1M | 8.69M | 3.37M | 3.83M | 9.52M | 8.05M |
| Earnings per share, basic | 1.67 | 1.22 | 0.25 | 0.42 | 0.89 | 0.38 | 0.15 | 0.17 | 0.46 | 0.39 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 30.7M | 30.9M | 24.5M | 13.1M | 4.26M | 13.3M | 27.0M | 36.3M | 37.1M | 27.5M |
| Short-term investments | -14.6M | -10.8M | -5.50M | -1.98M | -1.80M | -1.57M | -2.81M | |||
| Receivables | 56.5M | 60.8M | 61.1M | 78.9M | 86.6M | 77.7M | 46.9M | 38.1M | 20.5M | 21.1M |
| Inventory | 4.00M | 4.50M | 4.46M | 4.31M | 3.71M | 3.40M | 2.32M | 2.45M | 2.17M | 1.96M |
| Current assets | 91.1M | 97.4M | 92.5M | 101.6M | 100.5M | 94.4M | 75.2M | 78.4M | 64.3M | 56.4M |
| Property, plant and equipment | 227.1M | 248.7M | 269.7M | 256.5M | 140.6M | 146.8M | 161.3M | 159.3M | 61.9M | 45.5M |
| Goodwill | 253.8M | 254.9M | 251.8M | 251.0M | 188.9M | 173.6M | 173.6M | 169.9M | 103.9M | 92.3M |
| Total assets | 598.1M | 630.2M | 657.5M | 661.6M | 457.1M | 442.1M | 438.4M | 349.5M | 253.6M | 217.7M |
| Accounts payable | 88.7M | 24.1M | 27.1M | 41.7M | 52.6M | 45.3M | 18.6M | 18.8M | 12.6M | 8.02M |
| Current liabilities | 125.6M | 154.8M | 159.3M | 160.1M | 148.1M | 132.1M | 123.9M | 87.8M | 73.4M | 60.1M |
| Long-term debt | 103.1M | 114.6M | 144.0M | 167.5M | 91.4M | 92.5M | 103.9M | 94.3M | 35.3M | 25.7M |
| Total debt | 301.9M | 213.8M | 377.6M | 400.1M | 199.0M | 208.1M | 219.7M | 125.7M | 70.5M | 48.8M |
| Total liabilities | 425.5M | 461.3M | 512.9M | 538.8M | 334.5M | 327.1M | 332.4M | 218.4M | 147.7M | 116.7M |
| Shareholders' equity | 170.6M | 170.7M | 128.0M | 124.0M | 119.1M | 109.8M | 101.1M | 121.9M | 100.3M | 97.8M |
| Shares outstanding | 22.5M | 22.5M | 22.6M | 22.6M | 22.6M | 22.6M | 22.6M | 22.2M | 20.6M | 20.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 75.6M | 100.8M | 79.0M | 64.9M | 56.9M | 47.2M | 36.8M | 37.7M | 33.2M | 31.2M |
| Capital spending | -16.5M | -11.0M | -22.9M | -29.0M | -14.8M | -9.88M | -15.4M | -19.6M | -10.1M | -4.93M |
| Free cash flow | 59.1M | 89.8M | 56.1M | 35.8M | 42.1M | 37.3M | 21.4M | 18.1M | 23.1M | 26.3M |
| Cash from investing | -5.70M | -12.3M | -18.5M | -83.4M | -32.1M | -4.41M | -19.5M | -60.1M | -18.5M | -25.5M |
| Cash from financing | -70.1M | -82.2M | -49.2M | 27.4M | -33.9M | -56.5M | -26.7M | 31.9M | -6.86M | 5.41M |
| Dividends paid | -9.90M | -2.15M | -1.48M | -8.59M | -4.93M | -212.0K | -6.65M | -5.03M | -5.89M | -956.0K |
| Share buybacks | -3.10M | -937.0K | 0 | -1.48M | -582.0K | -692.0K | -29.0K | |||
| Change in cash | -200.0K | 6.39M | 11.4M | 8.87M | -9.05M | -13.7M | -9.31M | -758.0K | 9.54M | 12.2M |
Cap table
Built by 6ix from Pihlajalinna PLC’s releases
- Common shares
- 22,489,157
- Fully diluted
- 22,489,157
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 22,489,157 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 22,489,157 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Heikki Färkkilä | Executive Vice President, Strategy and Group Operations · Since at least Nov 5, 2026 |
| Heikki Tarkkila | Chief Commercial Officer · Since at least Feb 13, 2026 |
| Jaakko Liljeroos | Chief Legal Officer · Since at least Nov 5, 2026 |
| Lauri Muhonen | Chief Information Officer · Since at least Nov 5, 2026 |
| Mika Videman | Executive Vice President, People and culture · Since at least Nov 5, 2026 |
| Sari Riihijärvi | Chief Medical Officer · Since at least Nov 5, 2026 |
| Seppo Kariniemi | Executive Vice President, Healthcare services · Since at least Nov 5, 2026 |
| Tarja Rantala | Chief Financial Officer · Since at least Nov 5, 2026 |
| Tuomas Hyyryläinen | President and CEO · Since at least Sep 25, 2026 |
| Tuula Lehto | Executive Vice President, Communications, Marketing and Sustainability · Since at least Sep 25, 2026 |
Log in to ask 6ix AI your own questions about Pihlajalinna PLC.